#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the hypopharynx Angiosarcoma non-metastatic Marginal zone lymphoma refractory Inclusion body myositis Central nervous system lymphoma Partial lipodystrophy Hypotransferrinaemia Neutropenia Graft versus host disease Infective uveitis Congenital generalised lipodystrophy Vulval cancer Factor VIII deficiency Myelodysplastic syndrome with excess blasts Porphyria non-acute More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Basic Information Haemophilia A without inhibitors – Diagnostics Breast angiosarcoma Hereditary motor and sensory neuropathy – Diagnostics Burkitt’s lymphoma – Basic Information Usher’s syndrome Paroxysmal nocturnal haemoglobinuria Activated PI3 kinase delta syndrome Ehlers-Danlos syndrome – Life with Disease Paroxysmal nocturnal haemoglobinuria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [89ZR]ZR-DFO-CIT-013 Diacerein Citicoline Sodium Aficamten Phosphocreatine Sodium BUMETANIDE Human Fibrinogen Ketamine Clindamycin Phosphate Apocynin ATOVAQUONE Lorlatinib Fludarabine Phosphate Ph. Eur. Exagamglogene Autotemcel Pelareorep Amivantamab Skin Autograft Prx005 Vorasidenib Cefotaxime More therapies…

    Learn about Your Condition

    Alcoholic liver disease Electronic cigarette user Anxiety disorder Coma Endocarditis enterococcal Microvillous inclusion disease Vomiting Renal transplant Endocrine ophthalmopathy Endocarditis Neuroendocrine carcinoma Diabetic retinopathy Incontinence Aneurysm ruptured IgA nephropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gastrooesophageal cancer

  • Study on the Safety of Trifluridine/Tipiracil for Patients with Dihydropyrimidine Dehydrogenase Deficiency and Metastatic Colorectal or Gastroesophageal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Tipiracil
    • Trifluridine
    France

  • Study on MK-2870, Pembrolizumab, and Chemotherapy for Patients with Advanced Gastroesophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    Investigated Drugs:
    • H2-Receptor Antagonist
    • Patritumab Deruxtecan
    • Buclizine Hydrochloride
    France Germany Italy Norway

  • Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer recurrent
    • Gastrooesophageal cancer
    • Gastric cancer
    Investigated Drugs:
    • Levoleucovorin
    • Tipiracil Hydrochloride
    • Tipiracil
    France

  • Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Gastric cancer
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Trastuzumab Deruxtecan
    • Calcium Folinate
    Italy

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2+ Resectable Esophagogastric Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    • Gastrooesophageal cancer
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Trastuzumab Deruxtecan
    • Fluorouracil
    Austria Germany

  • Study of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Tipiracil Hydrochloride
    • Trifluridine
    Germany Spain
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!